CSL - Ordinary Share Capital


CSL reported $482.13M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Arca Biopharma USD 48.72M 338K Dec/2025
aTyr Pharma USD 16.65M 81.34M Dec/2025
Bio Path USD 9.24M 934K Sep/2025
Brainstorm Cell Therapeutics USD 11.04M 2K Dec/2025
Cara Therapeutics USD 9.38M 9.38M Sep/2025
CSL USD 482.13M 93.87M Dec/2025
Curis USD 12.93M 12.87M Dec/2025
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Immunic USD 120.38M 21.73M Dec/2025
Minerva Neurosciences USD 1000 0 Sep/2024
TherapeuticsMD USD 11K 0 Sep/2023